http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201071308-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-61
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-736
filingDate 2009-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201071308-A1
titleOfInvention PHARMACEUTICAL COMPOSITIONS FOR TREATMENT FOR WARFARE
abstract The present invention relates to pharmaceutical compositions for treating, and especially topical, warts and their use for treating warts. In particular, the present invention relates to pharmaceutical compositions for treating warts, comprising: a) from 0.1 to 10 wt.% Dimethicone; b) from 5 to 25 wt.% one or more vegetable oils; c) one or more pharmaceutically acceptable excipients and / or carriers; d) from 2 to 6 wt.% urea; and e) water to 100 wt.%.
priorityDate 2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 38.